Document is current
Any future updates will be listed below
-
Authors
Grasset, Eloïse M. http://orcid.org/0000-0001-9857-582X
Deshpande, Atul
Lee, Jae W.
Cho, Yeonju http://orcid.org/0009-0003-3983-8337
Shin, Sarah M.
Coyne, Erin M. http://orcid.org/0000-0002-0393-6600
Hernandez, Alexei
Yuan, Xuan
Zhang, Zhehao
Cimino-Mathews, Ashley
Ewald, Andrew J. http://orcid.org/0000-0002-1964-0740
Ho, Won Jin http://orcid.org/0000-0003-2644-5086
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54CA268083, P30CA006973, R21CA264004, U01CA284090, U54CA268083, P30CA006973)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Break Through Cancer
Emerald Foundation
Break Through Cancer, Maryland Cancer Moonshot
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Breast Cancer Research Foundation (23-048)
Hope Scarves Foundation, JKTG Foundation
- License Information
-
More Information
Article History
Received: 9 April 2024
Revised: 30 July 2024
Accepted: 6 August 2024
First Online: 20 August 2024
Competing interests
: AJE is a consultant for BioNTech, has unlicensed patents on biomarkers for cancer and on the use of antibodies as anti-cancer therapeutics, and his spouse is an employee of Immunocore. WJH reports patent royalties from Rodeo/Amgen, received grants from Sanofi and NeoTX (to Johns Hopkins), and speaking/travel honoraria from Exelixis and Standard BioTools. AC-M has received research grants from HeritX, Genentech, and Bristol Myers Squibb (to Johns Hopkins) and previously served as a consultant to Bristol Myers Squibb.
: Studies were conducted in accordance with the 1996 Declaration of Helsinki and were approved by the institutional review board (IRB, #NA_00084719) at the Johns Hopkins Hospital. Consents were waived based on IRB review of secondary research of de-identified archived tissue specimens.
